載入...
Platelet response during the second cycle of decitabine treatment predicts response and survival for myelodysplastic syndrome patients
Despite the efficacy of decitabine to myelodysplastic syndrome (MDS), there is a wide range of responses, and no definite predictive marker has been identified. This study aimed to describe the efficacy of decitabine and to identify potential predictors of response and survival in patients with MDS....
Na minha lista:
| 發表在: | Oncotarget |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Impact Journals LLC
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4599296/ https://ncbi.nlm.nih.gov/pubmed/25938546 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|